IBDEI0K9 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,683,0)
 ;;=INFECTIOUS DISEASE^10^74
 ;;^UTILITY(U,$J,358.4,684,0)
 ;;=DERMATOLOGY^3^74
 ;;^UTILITY(U,$J,358.4,685,0)
 ;;=HISTORY OF ILLNESS^9^74
 ;;^UTILITY(U,$J,358.4,686,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^74
 ;;^UTILITY(U,$J,358.4,687,0)
 ;;=INJURY/TRAUMA^11^74
 ;;^UTILITY(U,$J,358.4,688,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^21^74
 ;;^UTILITY(U,$J,358.4,689,0)
 ;;=SEXUAL TRAUMA^20^74
 ;;^UTILITY(U,$J,358.4,690,0)
 ;;=PAIN^16^74
 ;;^UTILITY(U,$J,358.4,691,0)
 ;;=OTHER REASONS^15^74
 ;;^UTILITY(U,$J,358.4,692,0)
 ;;=COMMON DIAGNOSES^1^74
 ;;^UTILITY(U,$J,358.4,693,0)
 ;;=PREVENTIVE MEDICINE CODES^18^74
 ;;^UTILITY(U,$J,358.4,694,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^74
 ;;^UTILITY(U,$J,358.4,695,0)
 ;;=SIGNS AND SYMPTOMS^1^75
 ;;^UTILITY(U,$J,358.4,696,0)
 ;;=CARDIO/VASCULAR^2^75
 ;;^UTILITY(U,$J,358.4,697,0)
 ;;=ENDOCRINE, METOBOLIC, NUTRITIONAL^3^75
 ;;^UTILITY(U,$J,358.4,698,0)
 ;;=EYES, EARS, & NOSE^4^75
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=GASTROINTESTINAL^5^75
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=GENITOURINARY & RENAL^6^75
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=MUSCULOSKETAL^7^75
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=NEUROLOGY^8^75
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=PULMONARY/RESPIRATORY^9^75
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=PSYCHIATRIC^10^75
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=SKIN^11^75
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=NURSING HOME VISITS^1^76
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=PULSE OXIMETRY^10^77
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=BLOOD PRESSURE READING^2^77
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=SELF-CARE MANAGEMENT^11^77
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=INJECTIONS^5^77
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=ADMINISTRATION OF INJECTION(S)^6^77
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=IMMUNIZATIONS^7^77
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=ADMINISTRATION OF IMMUNIZATION(S)^8^77
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=USE OF INHALER^14^77
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=BLOOD DRAW(S)^1^77
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=FAMILY CONSULTATION^3^77
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=WOUND CARE/TUBE CHANGE^15^77
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=INSERT CATHETER^9^77
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=SKIN TEST^12^77
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=HANDLING OF SPECIMEN(S)^4^77
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=TEAM CONFERENCE^13^77
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=ORTHOTIC DEVICES^2^78
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=THERAPY EVALUATIONS^3^78
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=HOME THERAPY SERVICES^1^78
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=PRIMARY DIAGNOSES^1^79
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=V CODES ^1^80
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=AMPUTATION STATUS^2^80
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=BRAIN DISORDERS^3^80
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=CARDIOPULMONARY^4^80
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=COMPLICATION DUE TO^5^80
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=FRACTURES-LATE EFFECTS^6^80
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=MENTAL DISORDERS^7^80
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^8^80
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=TERTIARY DX-TBI CODES^10^80
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^80
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^2^81
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^3^81
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=OTHER CODES^6^81
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^4^81
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=TEAM CONFERENCE^8^81
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=INTERACTIVE COMPLEXITY^5^81
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=SUBSTANCE ABUSE^7^81
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^1^81
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=ADJUSTMENT DISORDERS^2^82
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=ANXIETY DISORDERS^4^82
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=AMNESTICS^3^82
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=ORGANIC DISORDERS^13^82
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=DEMENTIA^8^82
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=DELIRIUM^7^82
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=BIPOLAR DISORDERS^5^82
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=PSYCHOSIS/OTHER^17^82
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=PERSONALITY DISORDERS^15^82
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=SEXUAL DISORDERS^19^82
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=SLEEP DISORDERS^20^82
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=OTHER DISORDERS^14^82
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^82
 ;;^UTILITY(U,$J,358.4,757,0)
 ;;=V CODES^23^82
 ;;^UTILITY(U,$J,358.4,758,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^82
 ;;^UTILITY(U,$J,358.4,759,0)
 ;;=DEPRESSION^9^82
 ;;^UTILITY(U,$J,358.4,760,0)
 ;;=MOOD DISORDERS (OTHER)^11^82
 ;;^UTILITY(U,$J,358.4,761,0)
 ;;=SCHIZOPHRENIA^18^82
 ;;^UTILITY(U,$J,358.4,762,0)
 ;;=SOMATIFORM DISORDERS^21^82
 ;;^UTILITY(U,$J,358.4,763,0)
 ;;=EATING DISORDERS^10^82
 ;;^UTILITY(U,$J,358.4,764,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^82
 ;;^UTILITY(U,$J,358.4,765,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^82
 ;;^UTILITY(U,$J,358.4,766,0)
 ;;=BRAIN DISORDERS^6^82
 ;;^UTILITY(U,$J,358.4,767,0)
 ;;=ESOPHAGUS^2^83
 ;;^UTILITY(U,$J,358.4,768,0)
 ;;=STOMACH/DUODENUM^8^83
 ;;^UTILITY(U,$J,358.4,769,0)
 ;;=SMALL BOWEL^7^83
 ;;^UTILITY(U,$J,358.4,770,0)
 ;;=LARGE BOWEL/RECTUM^4^83
 ;;^UTILITY(U,$J,358.4,771,0)
 ;;=SYMPTOMS^1^83
 ;;^UTILITY(U,$J,358.4,772,0)
 ;;=LIVER^5^83
 ;;^UTILITY(U,$J,358.4,773,0)
 ;;=PANCREAS^6^83
 ;;^UTILITY(U,$J,358.4,774,0)
 ;;=GALLBLADDER^3^83
 ;;^UTILITY(U,$J,358.4,775,0)
 ;;=ESOPHAGUS^3^84
 ;;^UTILITY(U,$J,358.4,776,0)
 ;;=SMALL INTESTINE ENDOSCOPY^8^84
 ;;^UTILITY(U,$J,358.4,777,0)
 ;;=SIGMOIDOSCOPY/PROCTOSIGMOIDOSCOPY^7^84
 ;;^UTILITY(U,$J,358.4,778,0)
 ;;=COLONOSCOPY^1^84
 ;;^UTILITY(U,$J,358.4,779,0)
 ;;=ERCP^2^84
 ;;^UTILITY(U,$J,358.4,780,0)
 ;;=G-TUBE^4^84
 ;;^UTILITY(U,$J,358.4,781,0)
 ;;=MISCELLANEOUS-PROCEDURES^6^84
 ;;^UTILITY(U,$J,358.4,782,0)
 ;;=IMMUNIZATIONS/INJECTIONS^5^84
 ;;^UTILITY(U,$J,358.4,783,0)
 ;;=NEW PATIENT^2^85
 ;;^UTILITY(U,$J,358.4,784,0)
 ;;=ESTABLISHED PATIENT^1^85
 ;;^UTILITY(U,$J,358.4,785,0)
 ;;=CONSULTATIONS^3^85
 ;;^UTILITY(U,$J,358.4,786,0)
 ;;=POST-OP FOLLOW-UP^4^85
 ;;^UTILITY(U,$J,358.4,787,0)
 ;;=HOSPICE CARE SUPERVISION^1^86
 ;;^UTILITY(U,$J,358.4,788,0)
 ;;=TEAM CONFERENCES^2^86
 ;;^UTILITY(U,$J,358.4,789,0)
 ;;=INPATIENT CONSULTATIONS^1^87
 ;;^UTILITY(U,$J,358.4,790,0)
 ;;=INITIAL INPATIENT CARE^2^87
 ;;^UTILITY(U,$J,358.4,791,0)
 ;;=SUBSEQUENT INPATIENT CARE^3^87
 ;;^UTILITY(U,$J,358.4,792,0)
 ;;=DISCHARGE/PRONOUNCEMENT^4^87
 ;;^UTILITY(U,$J,358.4,793,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^88
 ;;^UTILITY(U,$J,358.4,794,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^88
 ;;^UTILITY(U,$J,358.4,795,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^3^88
 ;;^UTILITY(U,$J,358.4,796,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^4^88
 ;;^UTILITY(U,$J,358.4,797,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^5^88
 ;;^UTILITY(U,$J,358.4,798,0)
 ;;=RENAL COND OTHER THAN CANCER^6^88
 ;;^UTILITY(U,$J,358.4,799,0)
 ;;=DERMATOLOGIC CONDITIONS^7^88
 ;;^UTILITY(U,$J,358.4,800,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^8^88
 ;;^UTILITY(U,$J,358.4,801,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^9^88
 ;;^UTILITY(U,$J,358.4,802,0)
 ;;=HOSPICE CARE SUPERVISION^1^89
 ;;^UTILITY(U,$J,358.4,803,0)
 ;;=TEAM CONFERENCES^2^89
 ;;^UTILITY(U,$J,358.4,804,0)
 ;;=NEW PATIENT ^2^90
 ;;^UTILITY(U,$J,358.4,805,0)
 ;;=ESTABLISHED PATIENT ^1^90
 ;;^UTILITY(U,$J,358.4,806,0)
 ;;=CONSULTATIONS ^3^90
 ;;^UTILITY(U,$J,358.4,807,0)
 ;;=CANCER & HEMATOLOGIC CONDITIONS^2^91
 ;;^UTILITY(U,$J,358.4,808,0)
 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^91
 ;;^UTILITY(U,$J,358.4,809,0)
 ;;=CNS CONDITIONS OTHER THAN CANCER^4^91
 ;;^UTILITY(U,$J,358.4,810,0)
 ;;=CARDIOPULMONARY COND OTHER THAN CANCER^3^91
 ;;^UTILITY(U,$J,358.4,811,0)
 ;;=GASTROINTESTINAL COND OTHER THAN CANCER^6^91
 ;;^UTILITY(U,$J,358.4,812,0)
 ;;=RENAL COND OTHER THAN CANCER^8^91
 ;;^UTILITY(U,$J,358.4,813,0)
 ;;=DERMATOLOGIC CONDITIONS^5^91
 ;;^UTILITY(U,$J,358.4,814,0)
 ;;=RHEUMATOLOGIC/VASCULITIC/THROMBOEMBOLIC^9^91
 ;;^UTILITY(U,$J,358.4,815,0)
 ;;=INFECTIOUS CONDITIONS & SIRS^7^91
 ;;^UTILITY(U,$J,358.4,816,0)
 ;;=RESPIRATORY^10^92
 ;;^UTILITY(U,$J,358.4,817,0)
 ;;=CARDIOVASCULAR^4^92
 ;;^UTILITY(U,$J,358.4,818,0)
 ;;=ABDOMINAL PAIN^2^92
 ;;^UTILITY(U,$J,358.4,819,0)
 ;;=AFTERCARE POST SURGERY^3^92
 ;;^UTILITY(U,$J,358.4,820,0)
 ;;=COMMON VASCULAR DX^1^92
 ;;^UTILITY(U,$J,358.4,821,0)
 ;;=POST-OP COMPLICATIONS^9^92
 ;;^UTILITY(U,$J,358.4,822,0)
 ;;=METASTATIC CANCER SITES^8^92
 ;;^UTILITY(U,$J,358.4,823,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^92
 ;;^UTILITY(U,$J,358.4,824,0)
 ;;=HEMATOLOGY/ONCOLOGY^6^92
 ;;^UTILITY(U,$J,358.4,825,0)
 ;;=INFECTIOUS DISEASE^7^92
 ;;^UTILITY(U,$J,358.4,826,0)
 ;;=BIOPSY^1^93
 ;;^UTILITY(U,$J,358.4,827,0)
 ;;=CENTRAL VENOUS ACCESS PROCEDURES^2^93
 ;;^UTILITY(U,$J,358.4,828,0)
 ;;=PERIPHERAL ANGIOPLASTIES^3^93
 ;;^UTILITY(U,$J,358.4,829,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^4^93
 ;;^UTILITY(U,$J,358.4,830,0)
 ;;=VASCULAR INJECTION PROCEDURES^5^93
 ;;^UTILITY(U,$J,358.4,831,0)
 ;;=MFH-NON CLINICIAN VISIT CODES^8^94
 ;;^UTILITY(U,$J,358.4,832,0)
 ;;=NURSING PROCEDURES^9^94
 ;;^UTILITY(U,$J,358.4,833,0)
 ;;=SPLINTS^10^94
 ;;^UTILITY(U,$J,358.4,834,0)
 ;;=MFH-CLINICIAN VISIT CODES^7^94
 ;;^UTILITY(U,$J,358.4,835,0)
 ;;=FUNCTIONAL RPTING MOBILITY^3^94
 ;;^UTILITY(U,$J,358.4,836,0)
 ;;=FUNCTIONAL RPTING BODY POSITION^1^94
 ;;^UTILITY(U,$J,358.4,837,0)
 ;;=FUNCTIONAL RPTING CARRY OBJECTS^2^94
 ;;^UTILITY(U,$J,358.4,838,0)
 ;;=FUNCTIONAL RPTING SELF CARE^6^94
 ;;^UTILITY(U,$J,358.4,839,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT PRI^4^94
 ;;^UTILITY(U,$J,358.4,840,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT SUB^5^94
 ;;^UTILITY(U,$J,358.4,841,0)
 ;;=CIRCULATORY SYSTEM/CARDIOLOGY^2^95
 ;;^UTILITY(U,$J,358.4,842,0)
 ;;=ENDOCRINE/NUTR/METABOLIC/IMMUN DISORDERS^5^95
 ;;^UTILITY(U,$J,358.4,843,0)
 ;;=RESPIRATORY SYSTEM^15^95
 ;;^UTILITY(U,$J,358.4,844,0)
 ;;=MUSCULOSKELETAL SYSTEM^12^95
